Amrubicin in previously treated patients with malignant pleural mesothelioma: A phase II study

類似資料

• Phase II study of nedaplatin and amrubicin as first‐line treatment for advanced squamous cell lung cancer
  著者:: Taniguchi, Hirokazu, 等
  出版事項: (2019)
• Phase II study of ramucirumab and docetaxel for previously treated non‐small cell lung cancer patients with malignant pleural effusion: Protocol of PLEURAM study
  著者:: Takemoto, Shinnosuke, 等
  出版事項: (2019)
• Phase I study of pemetrexed and concurrent radiotherapy for previously untreated elderly patients with locally advanced non‐squamous non‐small cell lung cancer
  著者:: Takemoto, Shinnosuke, 等
  出版事項: (2017)
• Diffuse alveolar hemorrhage with pseudoprogression during nivolumab therapy in a patient with malignant melanoma
  著者:: Ikeda, Takaya, 等
  出版事項: (2018)
• Dabrafenib and trametinib therapy in an elderly patient with non‐small cell lung cancer harboring the BRAF V600E mutation
  著者:: Dotsu, Yosuke, 等
  出版事項: (2020)